Academic Staff

                                        Rezvan Faisal Abduljabbar
Rezvan Faisal Abduljabbar None
Lecturer
Medical Oncology
  • 2015 PhD Oncology University of Nottingham UK
    2007 MSc Oncology University of Nottingham UK
    2003 MBChB Medicine and Surgery University of Duhok Iraq

  • Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
    MA Aleskandarany, R Abduljabbar, I Ashankyty, A Elmouna, D Jerjees, ...
    Breast cancer research and treatment 159, 215-227Breast cancer research and treatment 159, 215-227 90 2016
    Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
    R Abduljabbar, OH Negm, CF Lai, DA Jerjees, M Al-Kaabi, MR Hamed, ...
    Breast cancer research and treatment 150, 335-346 89 2015
    Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast CancerCDK7 Expression in Breast Cancer
    H Patel, R Abduljabbar, CF Lai, M Periyasamy, A Harrod, C Gemma, ...
    Clinical Cancer Research 22 (23), 5929-5938 72 2016
    Cancer Incidence Rates in the Kurdistan Region/Iraq from
    RT Othman, R Abdulljabar, A Saeed, S Sadiq, HM Kittani, SA Mohammed, ...
    Asian Pacific Journal of Cancer Prevention 12, 1261-1264 58 2011
    Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
    R Abduljabbar, MM Al-Kaabi, OH Negm, D Jerjees, AA Muftah, ...
    Breast cancer research and treatment 150, 511-522 32 2015
    ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer
    DA Jerjees, M Alabdullah, M Alkaabi, R Abduljabbar, A Muftah, C Nolan, ...
    Breast cancer research and treatment 147, 25-37 18 2014
    The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways
    DA Jerjees, OH Negm, ML Alabdullah, S Mirza, M Alkaabi, MR Hameed, ...
    Breast cancer research and treatment 150, 91-103 12 2015
    Dyslipidemia in subclinical hypothyroidism: a case-control study
    B Qasim, S Arif, A Mohammed, R Abduljabbar
    J Endocrinol Diab 5 (1), 1-6 11 2018
    BRCA1/2 Testing and/or Further Genetic Assessment Scoring Sheet: A Useful Clinical Tool
    RF Abduljabbar
    JOURNAL OF PATHOLOGY 243, S23-S23 2017
    EVALUATION OF SERUM ZINC LEVEL IN LIVER CIRRHOSIS PATIENTS IN DUHOK GOVERNORATE
    RF ABDULJABBAR, M HABEEB, A SALIH, BA QASIM
    Duhok Medical Journal 10 (1) 2016
    Clinicopathologic significance of androgen receptor expression in invasive breast cancer: A comprehensive analysis in large cohorts
    MA Aleskandarany, R Abduljabbar, S Sonbul, CF Lai, S Ali, ...
    European Journal of Cancer 1 (61), S207 2016
    Improvement of Ki67 Staining in Breast Cancer (BC)
    AA Muftah, M Aleskandarany, MM Al-Kaabi, DA Jerjees, RF Abduljabbar, ...
    JOURNAL OF PATHOLOGY 237, S30-S30 2015


  • my research is focused on the outcome of the treatment of medical oncology cases so it is related to the cancers that include breast, colon, prostate, lung and other solid cancers
    I am also interested in cancer epidemiology and statistics.

  • My teaching experience includes undergraduate level at college of health sciences for two years then when became a staff of the college of pharmacy on 2019 I started to teach undergraduate students several topics including medical statistics for stage I, drug informatics for stage III, therapeutics II for stage IV and hospital training and case study for stage V till now. I have also regularly taught and supervised higher education students including students of higher diploma, MSc, PhD and mostly Board students at the hospital on regular basis. I have a teaching experience of more then 10 years

  • MSc student Karwan Thirar Humoral immune response to Covid 19 vaccine

  • different various conferences (> 50) in the field such as the years Kurdistan Oncology Guideline summit, Core 2 conference about cancer research in Erbil, BEST of ASCO conference yearly in Kurdistan and many other conferences all over the world

  •   009647508921187
      rezvan.abduljabbar@uod.ac

  • Download